Pascal Juillerat MD MSc, IBD specialist

Gastroenterologist with special interest in inflammatory bowel diseases / gastro-entérologue spécialisé dans les MICI / Gastroenterologue mit CED Interesse.

[Robert Dudkowiak MD, PhD @drRobinDud]

Great lucter abt Acute Severe & Fulminant Colitis by @PascalJuillerat

Masterclass in IBD 💚
supervised by @DignassAxel & Stephan Vavricka

@my_ueg EDUCATION 💙
Vienna 🎡 2025

#UEG 💜 #IBD #UC #ASCU
.

[Beatriz Gros @Bealoquebea]

🤩 exciting days ahead

[Beatriz Gros @Bealoquebea]

Great talk by Bel Kok regarding disease monitoring in IBD at @my_ueg IBD masterclass

[United European Gastroenterology @my_ueg]

Course Directors: @DignassAxel, @VavrickaStephan
Faculty: @ign76, @Bealoquebea, @DrAilsaHart, @PascalJuillerat, Bel Klaartje Kok, James Lindsay, @PMyrelid, @edyta_tul, @bverstockt

[Keith Siau @drkeithsiau]

AGA 2025 clinical practice guidelines for Crohn’s disease 📌🆕

📸: https://t.co/9bG9hwxzAK

[roypounder.apt @APandT]

'Free to read' via https://t.co/FauSU9jShH
"Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease"
by Mahadevan et al
#IBD #GItwitter #pregnancy

[InternationalBowelUS @BowelUltrasound]

We’re pleased to announce the “ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with IBD,” a project involving IBUS, showing the role of IUS in the diagnosis and monitoring of IBD patients.

P.1: 10.1093/ecco-jcc/jjaf106
P.2: 10.1093/ecco-jcc/jjaf107

[Harry Sokol @h_sokol]

Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial - The Lancet Gastroenterology & Hepatology https://t.co/2lnmrPnrkp

[Manuel Barreiro @manu_barreiro]

Just Starting 4th Postgraduate Course #ECCO2025 #EDUCOM course with more than 350 attendees!
@UriKopylov @FernandoMagro6 with and a amazing talk from @SeverineVermei1

[Pascal Juillerat MD MSc, IBD specialist @PascalJuillerat]

Thank you for your contribution to this Great case discussion and long Life to the PG of ECCO ! @manu_barreiro @Iagorlago @UriKopylov #ECCO2025

[Manuel Barreiro @manu_barreiro]

Postgraduate course #ECCO2025 very interesting clinical case discussion!
@Iagorlago @PascalJuillerat

[José Antonio Olmos @joseantonio83]

New IBD classification. Florence classification @doc_ibd @IBDCedarsSinai #ECCO2025

[CGH @AGA_CGH]

Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial ➡️ https://t.co/zzml96NiMM

[Saqr Alsakarneh, MD, MS @AlsakarnehSaqr]

Just published in the American Journal of Therapeutics 🔥

JAKi in Chronic Inflammatory Pouch Conditions:
📌Clinical response: 43%
📌Endoscopic response: 48%
📌AEs: 16%
📌Primary treatment failure: 42%

📊JAKi are not recommended to be first line treatment in chronic pouch conditions ✔️

@JHashashMD @fouadsjaber @YazanAbboudMD @CrohnsColitisFn #GITwitter #IBD @MondayNightIBD

[Pascal Juillerat MD MSc, IBD specialist @PascalJuillerat]

Completely agree ! Amazing meeting and conclusions, congratulations! @EdwardLoftus2 @MLongMD @MRegueiroMD @DrCoreySiegel @NMH_SHanauerMD #AIBD2024

[Edward Loftus @EdwardLoftus2]

The whole conference in one slide #AIBD2024 @MRegueiroMD @MLongMD @DrCoreySiegel @NMH_SHanauerMD

[Remo Panaccione, MD, FRCPC @RPanaccione]

How can you not love Charles Bernstein ? Amazing career as a clinician scientist for over 30 years!!! Linking the learnings from IBD epidemiology to climate inform clinical practice @gilkaplan @EdwardLoftus2

[Dominik Bettenworth @BettenworthDb]

#ECCO UC Treatment Guideline Update - how it started...
@bverstockt @HolubarStefan @RajaAtreya @I_Blumenstein @AlaaEl_Hussuna @manu_barreiro @AnthonydeBuck @fgomollon @Max_Fantini @fede__furfaro @MariangelaAllo3 @PascalJuillerat @mjosecasanova @UriKopylov @EderPiotr et al.
#IBD

[alessandro armuzzi @alearmuzzi]

IBD Monitoring how&when. Tandem talk with #HagarBanaiEran from #rabinhospitalpetahtikva at #FalkSymposium238 in Florence. ⁦@HUNIMED⁩

[Pascal Juillerat MD MSc, IBD specialist @PascalJuillerat]

Luc Biedermann at #Falksymposium238 presenting on biological treatments in EoE. @IBD_USZ , Great job.

[Clive Miranda, DO, MSc @clivejmiranda]

🌟 Making a choice of therapy for IBD

Take into account extraintestinal concerns as well as contraindications to treatment!

🙏🏻 @IBDMD

#GITwitter #ACG2024 @AmCollegeGastro

[Remo Panaccione, MD, FRCPC @RPanaccione]

Nobel Prize winning concepts land in IBD. The discovery of power and importance of microRNA biology . @bruce_sands1 presenting the long term results of the phase 2a Obefazimod UC. Study . Is this the game changer? Calling all investigators . We need to get the phase III DONE !!!